T 0313/12 (Human atrial natriuretic peptide hANP O-acetylserine/DAIICHI) of 20.01.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T031312.20160120
- Date of decision
- 20 January 2016
- Case number
- T 0313/12
- Petition for review of
- -
- Application number
- 01930035.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD OF INHIBITING THE FORMATION OF BY-PRODUCT IN THE PRODUCTION OF GENETICALLY MODIFIED POLYPEPTIDE
- Applicant name
- Daiichi Sankyo Company, Limited
- Opponent name
- Takeda GmbH
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Main Request - admissibility (yes);
Main Request - meets all requirements EPC (yes) - Catchword
- -
- Cited cases
- G 0001/03
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the Main Request (claim 1) filed with the statement setting out the Grounds of Appeal and a description to be adapted thereto.